// App-Quantinova.ai

1066 : Genetic Abnormalities and Prognosis in Pediatric Bprecursor Acute Lymphoblastic Leukemia Treated on Tokyo Children?s Cancer Study Group Protocol

Researchers

Presenter

  • Kentaro Ohki

Principal Investigators

  • Myoung-ja Park

  • Yusuke Hara

  • Norio Shiba

  • Takashi Fukushima

  • Katsuyoshi Koh

  • Atsushi Manabe

  • Akira Ohara

  • Nobutaka Kiyokawa

  • Yasuhide Hayashi

Medical Centers

  • Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan

  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan

  • Department of Radiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  • Department of Hematology/Oncology, Gunma Red Cross Blood Center, Maebashi, Japan

  • Department of Pediatrics, St. Lukes International Hospital, Tokyo, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Cyclin Dependent Kinase Inhibitor 2A

  • ETS transcription factor ERG

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved